Mirae Asset Global Investments’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Mirae Asset Global Investments’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-47,185	Closed	-$5.46M	–	2651
2023 Q3	$5.46M	Sell	47,185 -332	-0.7%	-$35.7K	0.01%	839
2023 Q2	$4.89M	Buy	47,517 +7,429	+19%	+$784K	0.01%	888
2023 Q1	$4.38M	Sell	40,088 -5,825	-13%	-$644K	0.01%	908
2022 Q4	$5.22M	Sell	45,913 -35,422	-44%	-$2.94M	0.01%	810
2022 Q3	$5.03M	Buy	+81,335	New	+$5.68M	0.01%	799
2022 Q2	–	Sell	-85,614	Closed	-$9.01M	–	2503
2022 Q1	$9.01M	Buy	85,614 +538	+0.6%	+$52.4K	0.02%	698
2021 Q4	$9.17M	Buy	85,076 +77,949	+1,094%	+$8.5M	0.02%	705
2021 Q3	$780K	Sell	7,127 -8,919	-56%	-$926K	﹤0.01%	1379
2021 Q2	$1.5M	Buy	16,046 +11,026	+220%	+$1.01M	﹤0.01%	1145
2021 Q1	$462K	Buy	5,020 +263	+6%	+$22.2K	﹤0.01%	1316
2020 Q4	$348K	Buy	4,757 +355	+8%	+$26.4K	﹤0.01%	1407
2020 Q3	$342K	Buy	+4,402	New	+$303K	﹤0.01%	1308
2017 Q1	–	Sell	-34,868	Closed	-$564K	–	676
2016 Q4	$564K	Buy	+34,868	New	+$632K	0.01%	384
2016 Q1	–	Sell	-470,040	Closed	-$10.2M	–	523
2015 Q4	$10.2M	Buy	470,040 +28,400	+6%	+$553K	0.34%	71
2015 Q3	$8.75M	Buy	+441,640	New	+$14M	0.36%	72

Other funds holding HZNP

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Mirae Asset Global Investments's HZNP Position: Q4 2023 in Review

Mirae Asset Global Investments sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 47,185 shares — an estimated $5.46M sold.

Mirae Asset Global Investments first reported a position in HZNP in Q3 2015 and held it in 15 quarters. The position peaked at $10.2M in Q4 2015. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

Mirae Asset Global Investments reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Mirae Asset Global Investments sold 47,185 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $5.46M.
Mirae Asset Global Investments first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2015 and held it in 15 quarters.
Mirae Asset Global Investments's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $10.2M in Q4 2015.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Mirae Asset Global Investments's 13F filing for Q4 2023, filed 24 Jan 2024.